VaxiPatch based Coronavirus Vaccine / Verndari - LARVOL DELTA

Coronavirus Updates: The Latest Treatments and Vaccines - "'That trial did not find any difference in outcomes between the treatment and placebo,' said Yvonne Maldonado....Dr. Aruna Subramanian...lead investigator for the inpatient trial, said the 21 hospitalized patients in the study receive a high dose like Trump, a lower dose or a placebo. Subramanian plans to expand the inpatient trial to 45 patients. The outpatient study has enrolled a little more than 40 of the 60 patients researchers intend to sign up. 'There's enough promising evidence that it helps people early in the infection,' Subramanian said. 'What we don't know is whether it helps people who are pretty sick but not critically ill.'"

Clinical • Novel Coronavirus Disease